"We maintain our original conclusion that a target hematocrit value of 42% cannot be recommended

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1623, 2008-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

‘Because of the circumstances, we cannot develop our role’: Norwegian community pharmacists' perceived responsibility in role development

International Journal Of Pharmacy Practice, Vol. 23, Iss. 4, 2015-08 ,pp. : 256-265

John Wiley & Sons Inc

Access to resources Recommend Favorite

We are now accepting original research!

By Knowles Elizabeth Win Beta

Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. : 335-335

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant chemotherapy in patients with clinically well advanced prostate cancer (stage T3) after surgery `cannot be recommended'

Inpharma, Vol. 1, Iss. 1228, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Can we Target the Chemokine Network for Cancer Therapeutics?

Current Cancer Drug Targets, Vol. 6, Iss. 8, 2006-12 ,pp. : 659-670

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Obesity: Should We Target the Individual or Society?

Current Pharmaceutical Design, Vol. 9, Iss. 15, 2003-06 ,pp. : 1151-1163

Bentham Science Publishers

Access to resources Recommend Favorite